Find and Pitch Jounalists, Get Your Story Covered

	Profile	Recent Articles on Subject
1	Frank Vinluan MedCity News Medical innovation tracker. MedCity, USA medicalinnovation	Novo Nordisk Bets $200M on Triple-Targeting Drug for Obesity and Other Metabolic Diseases - 26 days ago The Chase for Novel Oral GLP-1 Obesity Meds Adds a New Contender - 4 months ago Novo Nordisk GLP-1 Drug Meets Goals of MASH Trial, Setting Stage for FDA & EMA Filings - 6 months ago Roche Weighs In With Encouraging Early Clinical Data for Oral GLP-1 Drug - 9 months ago Amylyx Aims to Help Patients With a Novel GLP-1 Drug, But Not the Way You Think - 9 months ago Navigating Opportunities and Challenges in the GLP-1 Drug Gold Rush - 11 months ago
2	Kristen Monaco MedPage Today	GLP-1 Agents Not Linked to Post-Op Aspiration Pneumonia, More Data Suggest - about 2 months ago Early-Stage GLP-1 Win in Obesity; An Argument for BMI's Value; Insulin Supply Issues - 9 months ago No Link Between GLP-1 Drugs and Suicide, Says European Regulator - about 1 year ago Insulin Out-of-Stock; Yet Another GLP/GIP Agonist; Digital Diabetes Tools Worth It? - about 1 year ago U.S. Rep's Death Medical Negligence? FDA Investigates GLPs; Fingerprint Mammograms - over 1 year ago Third Time's a Charm for GLP-1 Diabetes Device? FDA Staff Suggest Otherwise. - over 1 year ago
3	Emily Mullin Wired Staff writer at WIRED. Covers biotechnology. Fall 2021 fellow. Pittsburgh, Pennsylvania biotechnology	Your Love Life on Ozempic - 2 months ago
4	Amy Baxter Pharma Voice Scientist, inventor, former pediatrician. Atlanta, Georgia pain relieftechnologyinnovation	Beyond GLP-1s? This biotech is exploring longer-term metabolic treatments - 2 months ago GLP-1 compounding is still in limbo. Will the FDA leave it for the next administration? - 4 months ago Pfizer’s quest for market share in the ‘high stakes battleground’ of oral GLP-1s - 6 months ago
5	Will Norman PV Tech Senior reporter. London clean energysupply chainsmanufacturingtrade policyhuman rights	X-Elio signs 245GWh virtual PPA with pharmaceutical decarbonisation group - 2 months ago Encavis, LyondellBasell ink PPA for 260MW German PV project - about 1 year ago Lightsource bp signs corporate PPA with Microsoft for Polish PV - over 1 year ago
6	Emily Cooke Live Science Health reporter. London, United Kingdom healthscience	People with this rare genetic condition can't repair damage to their DNA - 2 months ago
7	Meghana Keshavan STAT News Biotech nerd and writer @statnews. biotechwriting	GLP-1 drugs spark disagreements in Trump’s circle - 4 months ago Versant enters obesity with new startup - 5 months ago
8	Ian Ingram MedPage Today Deputy Managing Editor. MedPage Today. New York, New York medical journalismediting	GLP-1 Drugs Tied to Reduced Risk of Dangerous Blood Clots - 4 months ago
9	Alana Hippensteele, Managing Editor Pharmacy Times #pharmacy news, insights. CE provider. Cranbury, New Jersey pharmacyhealthcarejournalism	GLP1 Agonists and Dietary Fiber May Reduce VTE Risk and Improve GVHD Outcomes - 4 months ago Data Show Lepodisiran Was Well Tolerated, Substantially Lowered Lipoprotein (a) - over 1 year ago
10	John Pinching PharmaTimes Next-gen biopharma company. La Jolla, California biopharmadrugsdevices	Pharma giants vie for oral GLP-1R approval - 5 months ago

Journalists covering lgp4